TauRx Pharma's effort to bring a tau-targeting drug for Alzheimer's disease (AD) to market has been a marathon, with a number of setbacks over the years, but the company reckons it may finally be ...
Joan K. Peters Ph.D. on January 4, 2026 in Transformative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback